Session 1: Analytical quality specifications | ||
The Milan 2014 consensus document | Sverre Sandberg | |
Biological variation database, time for an update? | Bill Bartlett | |
Common performance goals in EQA, is it possible? | Graham Jones | |
Session 2: Point-of-care testing | ||
Benefits and disadvantages of POCT | Gunnar Nordin | |
The challenges of quality assessment for POCT | Anne Stavelin | |
How to evaluate the performance of POC instruments? | -- | Grete Monsen |
EQA provider experience with POCT | Pierre-Alain Morandi | |
Session 3: Adam Uldall Lecture | ||
Performance criteria of point-of-care testing in modern medicine | -- | Sverre Sandberg |
Session 4: Harmonisation | ||
European harmonization initiatives | Ferruccio Ceriotti | |
40 years EQA experience – on the road to harmonisation? | Michael Spannagl | |
Update on UK Pathology Catalogue project | -- | Finlay Mackenzie |
Session 5: The members' session: Abstracts | ||
Acceptance sampling theory applied to EQA sample homogeneity testing | Wim Coucke | |
ProMeQualLab - Project of Laboratory Quality Improvement for Portuguese Speaking Countries | Ana Faria | |
Variables in the design of bone marrow morphology proficiency testing program: A ten year review of results from the Institute for Quality Management in Healthcare (IQMH), Canada | -- | Ruth Padmore |
How to determine acceptability limits based on biological variation in External Quality Assessment Schemes (EQAS): lymphocyte subsets as a case study | Mohamed Rida Soumali | |
External quality assessment programs in mycology - development of a scheme for galactomannan antigen detection | -- | Christine Walton |